Administration of Blood and Blood Products

• Coagulation Reference Binder
• Elements of Informed Consent for Blood and Blood Products
• Guide to Blood Component and Blood Product Administration
• Home Transfusion Guidelines

Adverse Event Reporting

• Algorithm for Transfusion Reactions/Investigation of Adverse Transfusion Reactions
• Provincial Reporting Process for Adverse Reactions

Blood and Blood Products

• C1 Esterase Inhibitors
  • Product Administration Guidelines Berinert®
  • Product Administration Guidelines Cinryze®
• Components
  • Nova Scotia Guideline for Blood Component Utilization in Adults and Pediatrics
  • Guideline for Washed Red Blood Cells in Nova Scotia
  • NS Red Blood Cell Transfusion Pathway
• Dabigatran and Rivaroxaban
  • Managing Bleeding
  • Blood Guidelines Reference List​
• Factor Product Sheets
  • Product Administration Guidelines Advate®
  • Product Administration Guidelines BeneFIX®
  • Product Administration Guidelines Corifact™
  • Product Administration Guidelines Feiba NF  
  • Product Administration Guidelines Humate-P®
  • Product Administration Guidelines Kogenate FS
  • Product Administration Guidelines NiaStase RT®
  • Product Administration Guidelines RiaSTAP™
  • Product Administration Guidelines Tretten®
  • Product Administration Guidelines Wilate®
  • Product Administration Guidelines Xyntha® and Xyntha® Solofuse™   

Immunoglobulins

• Memorandum: Atlantic Ministries of Health Common Policy for the Utilization of Intravenous and Subcutaneous Immunoglobulins
• Atlantic Ministries of Health Common Policy for the Use of Intravenous and Subcutaneous Immunoglobulin
• Atlantic Clinical Indications and Criteria for Intravenous and Subcutaneous Immunoglobulin (IVIG/SCIG) Version 1.0

• Intravenous Immunoglobulin (IVIG)
  • Adjusted Body Weight Calculator with IVIG Dosing for Adults
  • Product Administration Guidelines  Intravenous Immune Globulins (IVIG) – Both Adult and Pediatric
  • Cytogam Infusion Rate Table
  • Product Administration Guidelines Cytogam®
  • Gammagard Liquid Infusion Rate Table
  • Gammagard SD Infusion Rate Table
  • Gamunex-IGIVnex Infusion Rate Table
  • Octagam Infusion Rate Table
  • Privigen Infusion Table
  • Privigen Product information
  • Panzyga Infusion Rate Table
• Subcutaneous Immunoglobulin (SCIG)
  • Addendum to the Atlantic Guidelines for Subcutaneous Immunoglobulin (SCIG) Home Administration Programs
  • Atlantic Guidelines for Subcutaneous Immune Globulin Home Administration Programs
  • Curvitru Administration Guide
  • National Advisory Committee (NAC) Recommendations for SCIG
• Immunoglobulin – Other
  • Product Administration Guidelines - GamaSTAN® 
  • Product Administration Guidelines – HyperHEP B® S/D
  • Product Administration Guidelines - VariZIG™ 
• Massive Transfusion
  • Guideline for the Appropriate Use of Blood Components/Products
  • Massive Transfusion Algorithm
  • User’s Guide for the Massive Bleeding Data Collection Form
• Prothrombin Complex Concentrates (Octaplex® and Beriplex®P/N) The NSPBCP does not endorse any one product
  • Product Administration Guidelines - Beriplex®
  • Product Administration Guidelines - Octaplex®
  • National Advisory Committee (NAC) Recommendations for Use of Prothrombin Complex Concentrates in Canada
  • Prothrombin Complex Concentrate Reconstitution Guide (YouTube Video)
  • Utilization Guidelines for Prothrombin Complex Concentrates in Nova Scotia
• Rh Testing
  • Guideline for Rh Testing in Nova Scotia
  • Laboratory Pre-Natal RhD Typing Flowchart
  • Laboratory Rh Typing Flowchart – All Samples Except Pre-Natal
• S/D Plasma
  • Administration Guidelines Octaplasma (S/D Treated Human Plasma)
  • Framework for Appropriate Use and Distribution of Solvent Detergent Treated Plasma in Canada
• Blood Emergency Preparedness
• The Provincial Blood Contingency Plan
• National Plan for the Management of Shortages of labile Blood Components
• Emergency framework for rationing of blood for massively bleeding patients during a red phase of a blood shortage

Recipient Recall Notification

• NAC Recommendations for the Notification of Recipients of a Blood Component Recall